Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

For patients with non-small-cell lung cancer

Toxic Skin Effects Common With EGFR-TKI Use in NSCLC

0
Afatinib therapy linked to earlier paronychia onset; more dermatological visits for skin toxic effects
Postmenopausal women with hormone receptor-positive ductal carcinoma in situ have similar recurrence rates of disease whether they take tamoxifen or the aromatase inhibitor anastrozole after surgery

SABCS: Tamoxifen, Anastrozole Both Prevent Recurrence in DCIS

0
However, side effects differ for the two medications
Patients with rheumatoid arthritis have increased herpes zoster risk with older age and higher prednisone dose

Herpes Zoster Risk in RA Up With Older Age, Prednisone Dose

0
HZ risk comparable after initiation of TNFi, non-TNFi, and conventional synthetic DMARDs
Pharmaceutical industry-sponsored studies are more likely to report favorable estimates in cost-effectiveness analysis of drugs used in breast cancer treatment

Industry-Led Oncology Trials May Inflate Cost-Effectiveness

0
Breast cancer cost-effectiveness analyses show favorable estimates with industry funding
Nitrates don't improve quality of life or everyday activity levels as intended in patients with heart failure

Nitrates in Heart Failure May Harm More Than Help

0
Nitrates reduce activity, quality of life, researchers find
Taking warfarin at the same time as glipizide or glimepiride may increase the risk of hospitalization

Warfarin + Sulfonylureas May Increase Risk of Hospitalization

0
Risk found especially high for men aged 65 to 74

American Society of Hematology, Dec. 5-8

0
The 57th American Society of Hematology Annual Meeting and Exposition The annual meeting of the American Society of Hematology was held from Dec....
Capecitabine appears to reduce risk of recurrence for breast cancer patients with residual disease after presurgery chemotherapy

SABCS: Adding Capecitabine Ups Outcomes for Breast CA Patients

0
Linked to longer disease-free survival; second study links denosumab to reduced risk of recurrence
Cardiometabolic outcomes and safety vary among different once-weekly glucagon-like peptide-1 receptor agonist treatments

Review Compares Outcomes, Safety for Once-Weekly GLP-1RAs

0
Greater reduction of HbA1c, fasting plasma glucose, body weight for dulaglutide, exenatide, taspoglutide
For patients with inflammatory bowel disease treated with anti-tumor necrosis factor therapy

Skin Lesions for 29 Percent With Anti-TNF Treatment in IBD

0
All but 11 percent of patients were managed successfully without needing to stop treatment